SAN DIEGO, May 28, 2015 (GLOBE NEWSWIRE) -- ICON Vapor, Inc. (OTCQB:ICNV) is pleased to announce that the company is on track with its distribution strategy of expanding its presence in North America by continuing to develop a strategic relationship with Core-Mark International.
Icon Vapor's CEO, Dan Balsiger stated, "Our President of Sales and management team have been on the road non-stop over the last month, implementing our distribution plan and increasing Icon Vapor's North American presence at retail."
Dan went on to say, "We have also had some great meetings and have made significant progress in expanding our consumer reach in the Canadian market with our goal of becoming a nationally recognized brand. Additionally we have had some very positive meetings with Core-Mark in Ohio. The Ohio distribution center covers a significant swath of the country, one that we see as extremely valuable as the vapor business continues to gain consumer acceptance."
Icon Vapor's CEO stated further, "We feel that both of these markets provide our company with the opportunity to see a significant increase in both sales volume as well as profitability as we progress through quarter two and three of 2015"
About ICON Vapor, Inc.:
Headquartered in San Diego, California, ICON Vapor, Inc. engages in the manufacture and distribution of Ultra Premium Vapor Products. The company offers a wide variety of Vapor Products, Vape Pens & E-Liquids that are made in the USA, all branded under the ICON Vapor Products line. For further information please contact the Company at: ir@iconvapor.com.
Safe Harbor Statement:
This press release may contain forward looking statements and or observations which are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues as well as any payment of dividends on our stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties include but not limited to information as contained within the Company's most current quarterly reports, annual reports, and or other such filings as may be accessed through the OTC website. Furthermore, the Company disclaims any intention or obligation to update or revise any such forward looking statements, whether as a result of new information, future events, or otherwise. We have incurred and will continue to incur significant expenses in our expansion of our existing as well as new product lines noting there is no assurance that we will generate enough revenues to offset those costs. Additional product offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the variables as associated with the general business channel we are operating in, the impact of which cannot be predicted at this time including risks as associated with our product and recent FDA pronouncements.